Bhaskar Upadhyaya

979 total citations
16 papers, 425 citations indexed

About

Bhaskar Upadhyaya is a scholar working on Oncology, Hematology and Immunology. According to data from OpenAlex, Bhaskar Upadhyaya has authored 16 papers receiving a total of 425 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 7 papers in Hematology and 7 papers in Immunology. Recurrent topics in Bhaskar Upadhyaya's work include Multiple Myeloma Research and Treatments (6 papers), CAR-T cell therapy research (5 papers) and Immune Cell Function and Interaction (4 papers). Bhaskar Upadhyaya is often cited by papers focused on Multiple Myeloma Research and Treatments (6 papers), CAR-T cell therapy research (5 papers) and Immune Cell Function and Interaction (4 papers). Bhaskar Upadhyaya collaborates with scholars based in United States, United Kingdom and India. Bhaskar Upadhyaya's co-authors include Calman Prussin, Yuzhi Yin, Daniel C. Douek, Brenna J. Hill, Adeeb Rahman, Samir Parekh, Sundar Jagannath, Oliver Van Oekelen, Alessandro Laganà and Adolfo Aleman and has published in prestigious journals such as Nature Medicine, Blood and The Journal of Immunology.

In The Last Decade

Bhaskar Upadhyaya

15 papers receiving 421 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bhaskar Upadhyaya United States 9 178 142 128 87 62 16 425
Daniel Hollyman United Kingdom 6 321 1.8× 146 1.0× 171 1.3× 54 0.6× 62 1.0× 10 499
Cecilia Barese United States 13 383 2.2× 381 2.7× 178 1.4× 68 0.8× 22 0.4× 25 674
Tatsunori Goto Japan 14 435 2.4× 240 1.7× 216 1.7× 152 1.7× 19 0.3× 48 723
Nobuhiko Imahashi Japan 14 306 1.7× 283 2.0× 111 0.9× 183 2.1× 15 0.2× 41 622
Andrea Arruda Canada 10 163 0.9× 255 1.8× 188 1.5× 159 1.8× 25 0.4× 39 566
Bettina P. Iliopoulou United States 10 250 1.4× 323 2.3× 101 0.8× 55 0.6× 14 0.2× 15 531
Anna Capsomidis United Kingdom 5 381 2.1× 397 2.8× 129 1.0× 29 0.3× 18 0.3× 7 622
Serena Scala Italy 9 133 0.7× 118 0.8× 184 1.4× 84 1.0× 26 0.4× 17 371
Tomoyuki Ogura Japan 11 157 0.9× 330 2.3× 120 0.9× 101 1.2× 44 0.7× 28 558
Peter van Mourik Netherlands 11 76 0.4× 255 1.8× 70 0.5× 26 0.3× 29 0.5× 26 524

Countries citing papers authored by Bhaskar Upadhyaya

Since Specialization
Citations

This map shows the geographic impact of Bhaskar Upadhyaya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bhaskar Upadhyaya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bhaskar Upadhyaya more than expected).

Fields of papers citing papers by Bhaskar Upadhyaya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bhaskar Upadhyaya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bhaskar Upadhyaya. The network helps show where Bhaskar Upadhyaya may publish in the future.

Co-authorship network of co-authors of Bhaskar Upadhyaya

This figure shows the co-authorship network connecting the top 25 collaborators of Bhaskar Upadhyaya. A scholar is included among the top collaborators of Bhaskar Upadhyaya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bhaskar Upadhyaya. Bhaskar Upadhyaya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Oekelen, Oliver Van, Michael Amatangelo, Manman Guo, et al.. (2024). Iberdomide increases innate and adaptive immune cell subsets in the bone marrow of patients with relapsed/refractory multiple myeloma. Cell Reports Medicine. 5(6). 101584–101584. 7 indexed citations
2.
Aleman, Adolfo, Bhaskar Upadhyaya, Oliver Van Oekelen, et al.. (2023). P-175 Improving Anti-BCMA CAR-T functionality with novel immunomodulatory agent Iberdomide (CC220) in Multiple Myeloma. Clinical Lymphoma Myeloma & Leukemia. 23. S131–S132. 6 indexed citations
3.
Anaza, Nwamaka A., et al.. (2023). Is it FOMO or is it ME? The influence of personality traits on cryptocurrency consumption. Psychology and Marketing. 41(1). 184–202. 16 indexed citations
4.
Chen, Lucia, Oliver Van Oekelen, Michael Amatangelo, et al.. (2023). Mezigdomide Treatment in Relapsed-Refractory Myeloma Patients Shifts Bone Marrow NK and T Cell Populations from Exhaustion to Activation. Blood. 142(Supplement 1). 4686–4686. 4 indexed citations
5.
Thibaud, Santiago, Oliver Van Oekelen, Tarek H. Mouhieddine, et al.. (2022). Comprehensive Characterization of Prolonged Unexplained Cytopenias in Relapsed/Refractory Multiple Myeloma Patients Following BCMA-Directed CAR-T Cell Therapy. Blood. 140(Supplement 1). 614–616. 17 indexed citations
6.
7.
Varricchio, Lilian, Camelia Iancu‐Rubin, Bhaskar Upadhyaya, et al.. (2021). TGF-β1 protein trap AVID200 beneficially affects hematopoiesis and bone marrow fibrosis in myelofibrosis. JCI Insight. 6(18). 39 indexed citations
8.
Oekelen, Oliver Van, Adolfo Aleman, Bhaskar Upadhyaya, et al.. (2021). Neurocognitive and hypokinetic movement disorder with features of parkinsonism after BCMA-targeting CAR-T cell therapy. Nature Medicine. 27(12). 2099–2103. 151 indexed citations
9.
Oekelen, Oliver Van, Michael Amatangelo, Manman Guo, et al.. (2021). Large-Scale Mass Cytometry Reveals Significant Activation of Innate and Adaptive Immunity in Bone Marrow Tumor Microenvironment of Iberdomide-Treated Myeloma Patients. Blood. 138(Supplement 1). 730–730. 7 indexed citations
10.
Melnekoff, David T., Yogita Ghodke‐Puranik, Oliver Van Oekelen, et al.. (2021). Single-Cell Profiling Reveals Contribution of Tumor Extrinsic and Intrinsic Factors to BCMA-Targeted CAR-T Cell Efficacy in Multiple Myeloma. Blood. 138(Supplement 1). 326–326. 7 indexed citations
11.
Geanon, Daniel, Brian Lee, Edgar Gonzalez‐Kozlova, et al.. (2021). A streamlined whole blood CyTOF workflow defines a circulating immune cell signature of COVID ‐19. Cytometry Part A. 99(5). 446–461. 23 indexed citations
12.
13.
Fan, Xiying, Bhaskar Upadhyaya, Liming Wu, et al.. (2012). CD40 agonist antibody mediated improvement of chronic Cryptosporidium infection in patients with X-linked hyper IgM syndrome. Clinical Immunology. 143(2). 152–161. 16 indexed citations
14.
Upadhyaya, Bhaskar, Yuzhi Yin, Brenna J. Hill, Daniel C. Douek, & Calman Prussin. (2011). Hierarchical IL-5 Expression Defines a Subpopulation of Highly Differentiated Human Th2 Cells. The Journal of Immunology. 187(6). 3111–3120. 81 indexed citations
15.
Prussin, Calman, Yuzhi Yin, & Bhaskar Upadhyaya. (2010). TH2 heterogeneity: Does function follow form?. Journal of Allergy and Clinical Immunology. 126(6). 1094–1098. 31 indexed citations
16.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel Hollyman Breakdown of academic impact, for papers by Cecilia Barese Breakdown of academic impact, for papers by Tatsunori Goto Breakdown of academic impact, for papers by Nobuhiko Imahashi Breakdown of academic impact, for papers by Andrea Arruda Breakdown of academic impact, for papers by Bettina P. Iliopoulou Breakdown of academic impact, for papers by Anna Capsomidis Breakdown of academic impact, for papers by Serena Scala Breakdown of academic impact, for papers by Tomoyuki Ogura Breakdown of academic impact, for papers by Peter van Mourik
Rankless by CCL
2026